| Literature DB >> 21171956 |
Abstract
Conventional vaccine production techniques are outdated, leaving the world defenseless to viruses and pathogens. Successful protection necessitates the innovation of strategies that can generate an induced defensive humoral and cellular response with: ease of mass production, nominal side-effects, and controlled design specificity, all while being cost effective. Fortunately, technology exists to facilitate such advances in this billion dollar industry and this review is focused on recent publications and patents which hold promise to revolutionize the fight against pathogenic illnesses.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21171956 PMCID: PMC3020102 DOI: 10.2174/187220810793611518
Source DB: PubMed Journal: Recent Pat Biotechnol ISSN: 1872-2083